Literature DB >> 17095961

[Diagnosis of flat epithelial atypia (FEA) after stereotactic vacuum-assisted biopsy (VAB) of the breast: What is the best management: systematic surgery for all or follow-up?].

N David1, C Labbe-Devilliers, D Moreau, D Loussouarn, L Campion.   

Abstract

OBJECTIVE: FEA lesions group two histological types: columnar cell hyperplasia with atypia (CCHA) and columnar cell change with atypia (CCA). The increasing use of VAB has resulted in increased detection of isolated FEA lesions. The aim of this study was to define the best management possible for these patients: which cases may not need excision?
MATERIAL AND METHODS: From our database of 780 VABs carried out from 2000 to 2004, 59 patients with FEA were diagnosed. Cases in which no surgery was performed or all features were not available were excluded, thus excluding 19 cases. Forty patients with FEA were included. We reviewed clinical and mammographic characteristics, histological biopsy, and the corresponding surgically excised tissue features.
RESULTS: VAB yielded 25 cases of CCHA and 15 cases of CCA. Surgery revealed seven ductal carcinoma cases (four invasive, three in situ); nine benign lesions, and 24 with atypia (19 FEA and six atypical ductal hyperplasia). We found two features related to the risk of cancer: the presence and the size of hyperplasia. All carcinomas were found within the CCHA lesions. No cancer was yielded when size was less than 10 mm within CCA lesions and lesions that were totally removed.
CONCLUSION: We recommend surgical excision when CCHA greater than 10 mm is found on the VAB or it is incompletely removed. CCA lesions or CCHA less than 10 mm or totally removed may obviate systematic surgery.

Entities:  

Mesh:

Year:  2006        PMID: 17095961     DOI: 10.1016/s0221-0363(06)74145-2

Source DB:  PubMed          Journal:  J Radiol        ISSN: 0221-0363


  6 in total

1.  B3 Lesions: Radiological Assessment and Multi-Disciplinary Aspects.

Authors:  Sylvia H Heywang-Köbrunner; Jörg Nährig; Astrid Hacker; Stefan Sedlacek; Heinz Höfler
Journal:  Breast Care (Basel)       Date:  2010-08-23       Impact factor: 2.860

2.  Histologic associations and long-term cancer risk in columnar cell lesions of the breast: a retrospective cohort and a nested case-control study.

Authors:  Fouad I Boulos; William D Dupont; Jean F Simpson; Peggy A Schuyler; Melinda E Sanders; Marcia E Freudenthal; David L Page
Journal:  Cancer       Date:  2008-11-01       Impact factor: 6.860

Review 3.  Are columnar cell lesions the earliest histologically detectable non-obligate precursor of breast cancer?

Authors:  Gulisa Turashvili; Malcolm Hayes; Blake Gilks; Peter Watson; Samuel Aparicio
Journal:  Virchows Arch       Date:  2008-04-24       Impact factor: 4.064

4.  Update 2010 of the German AGO Recommendations for the Diagnosis and Treatment of Early and Metastatic Breast Cancer - Chapter B: Prevention, Early Detection, Lifestyle, Premalignant Lesions, DCIS, Recurrent and Metastatic Breast Cancer.

Authors:  Christoph Thomssen; Nadia Harbeck
Journal:  Breast Care (Basel)       Date:  2010-10-27       Impact factor: 2.860

Review 5.  Upgrade rates of high-risk breast lesions diagnosed on core needle biopsy: a single-institution experience and literature review.

Authors:  Kelly L Mooney; Lawrence W Bassett; Sophia K Apple
Journal:  Mod Pathol       Date:  2016-08-19       Impact factor: 7.842

6.  Flat epithelial atypia diagnosed on core needle biopsy-Clinical challenge.

Authors:  Karol Polom; Dawid Murawa; Paweł Murawa
Journal:  Rep Pract Oncol Radiother       Date:  2012-02-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.